IMMUNOLOGY LETTERS

Scope & Guideline

Connecting Researchers to the Heart of Immunology

Introduction

Explore the comprehensive scope of IMMUNOLOGY LETTERS through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore IMMUNOLOGY LETTERS in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN0165-2478
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1979 to 2024
AbbreviationIMMUNOL LETT / Immunol. Lett.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

IMUNOLOGY LETTERS focuses on the intricate mechanisms of the immune system, exploring its role in health and disease. The journal aims to publish high-quality research that enhances our understanding of immunological processes and their implications for therapeutic strategies.
  1. Immunological Mechanisms:
    The journal consistently publishes research on the fundamental mechanisms of the immune system, including cellular interactions, signaling pathways, and the roles of various immune cells like T cells, B cells, and macrophages.
  2. Autoimmunity and Inflammation:
    A significant portion of the research addresses autoimmune diseases and inflammatory responses, elucidating the underlying pathophysiology and potential therapeutic interventions.
  3. Cancer Immunology:
    Research related to cancer immunology is a prominent focus, exploring immune evasion by tumors, the role of immune checkpoints, and novel immunotherapies.
  4. Infectious Diseases:
    The journal includes studies on immune responses to infectious agents, including viral, bacterial, and parasitic pathogens, highlighting both basic and translational research.
  5. Therapeutic Advances:
    A unique contribution of the journal is its emphasis on therapeutic advances, discussing novel immunotherapeutic strategies, vaccine development, and targeted therapies in various disease contexts.
Recent publications in IMMUNOLOGY LETTERS indicate a clear trend towards specific emerging themes that reflect the evolving landscape of immunology research. These trends are crucial for researchers to consider as they shape future studies and therapeutic approaches.
  1. Immune Cell Plasticity:
    There is a growing interest in the plasticity of immune cells, particularly T cells and macrophages, as researchers explore how these cells adapt their functions in various disease states.
  2. Microbiome and Immunity:
    The role of the microbiome in modulating immune responses is an emerging theme, with studies increasingly focusing on gut microbiota's impact on health and disease, including autoimmune disorders.
  3. Targeted Immunotherapies:
    Research on targeted immunotherapies, particularly in cancer and chronic inflammatory diseases, is on the rise, highlighting innovative approaches to manipulate the immune response for therapeutic benefit.
  4. Long COVID and Immunity:
    The exploration of immune responses in the context of Long COVID is gaining traction, reflecting the ongoing impact of the COVID-19 pandemic on immunological research priorities.
  5. Nanotechnology in Immunotherapy:
    Emerging studies are focusing on the application of nanotechnology in enhancing immunotherapy, which presents novel strategies for targeted drug delivery and improved therapeutic efficacy.

Declining or Waning

While certain themes remain robust, some areas of research have experienced a decline in focus within the recent publications of IMMUNOLOGY LETTERS. These waning scopes suggest a shift in research priorities or emerging interests in the field.
  1. Basic Immunology Studies:
    There appears to be a waning interest in purely basic immunology studies without direct clinical or therapeutic implications, as the journal increasingly favors research with translational relevance.
  2. Older Vaccine Technologies:
    Research on traditional vaccine technologies has declined, likely giving way to emerging studies on mRNA and vector-based vaccines, reflecting the rapid evolution in vaccine development.
  3. Epidemiological Studies:
    Epidemiological studies related to immune responses have become less frequent, possibly overshadowed by more mechanistic or therapeutic-focused research.

Similar Journals

INTERNATIONAL REVIEWS OF IMMUNOLOGY

Unlocking Insights in Immunology and Allergy
Publisher: TAYLOR & FRANCIS INCISSN: 0883-0185Frequency: 6 issues/year

INTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.

Immunity Inflammation and Disease

Unveiling cutting-edge research on immunity and inflammation.
Publisher: WILEYISSN: Frequency: 12 issues/year

Immunity, Inflammation and Disease is a premier open-access journal published by WILEY, dedicated to advancing the field of immunology and allergy. Launched in 2013, this journal has established itself as a significant platform for researchers and professionals to disseminate high-quality research findings and innovative insights that address critical issues in immune responses and inflammatory diseases. With an impact factor that reflects its growing influence and a current ranking in Q3 for Immunology and Q2 for Immunology and Allergy, this journal serves a diverse audience keen on exploring cutting-edge developments. Researchers are encouraged to submit their work to share their findings with a global reach, foster collaboration, and enhance the understanding of immune mechanisms and therapeutic strategies. Accessible since its inception, Immunity, Inflammation and Disease is committed to open science, ensuring that vital research is freely available for the advancement of knowledge within the academic community and beyond.

Immune Network

Connecting Ideas, Transforming Immunology
Publisher: KOREA ASSOC IMMUNOLOGISTSISSN: 1598-2629Frequency: 6 issues/year

Immune Network is a prestigious journal dedicated to disseminating high-quality research in the field of immunology, infectious diseases, and allergy, under the esteemed KOREA ASSOCIATION OF IMMUNOLOGISTS. Founded in 2016, this journal has quickly ascended to a top-tier publication, achieving Q1 rankings in 2023 in multiple relevant categories, including Immunology, Allergy, and Infectious Diseases. With a strong emphasis on innovation and interdisciplinary research, Immune Network appeals to a diverse audience of researchers, professionals, and students keen on advancing the understanding of immune responses and disease mechanisms. However, it is crucial to note that the journal operates under a subscription model without open-access provisions. Its impact factor further solidifies its reputation, reflecting the significant influence of the articles published. Located in South Korea, the journal serves as a global platform for sharing revolutionary insights and fostering collaborations within the immunology community.

INFLAMMATION RESEARCH

Illuminating the pathways of inflammation research.
Publisher: SPRINGER BASEL AGISSN: 1023-3830Frequency: 12 issues/year

INFLAMMATION RESEARCH, published by SPRINGER BASEL AG, serves as a pivotal journal in the fields of Immunology and Pharmacology, with notable rankings of Q2 in Immunology and Q1 in Pharmacology as of 2023. With an ISSN of 1023-3830 and an E-ISSN of 1420-908X, this esteemed journal, located in Basel, Switzerland, has been at the forefront of advancing our understanding of inflammatory processes since its inception in 1995. Covering research trends and breakthroughs until 2024, it significantly contributes to both the theoretical frameworks and practical applications within its discipline, boasting a strong Scopus ranking of #40/313 in Pharmacology and #56/236 in Immunology, placing it in the top percentiles for its field. Although it does not offer Open Access options, the journal remains an invaluable resource for researchers, professionals, and students committed to unraveling the complexities of inflammation and its implications in health and disease.

TRENDS IN IMMUNOLOGY

Connecting Researchers with Cutting-Edge Immunological Discoveries
Publisher: CELL PRESSISSN: 1471-4906Frequency: 12 issues/year

TRENDS IN IMMUNOLOGY, published by CELL PRESS, stands as a premier source of insights and developments within the field of immunology. With an ISSN of 1471-4906 and E-ISSN of 1471-4981, this journal has established a strong reputation, evidenced by its prestigious status in Q1 quartiles for both Immunology and Allergy in 2023. It is ranked #13 out of 233 in the Scopus category of Medicine – Immunology and Allergy, and #16 out of 236 in Immunology and Microbiology, placing it within the top 94th and 93rd percentiles respectively. Since its inception in 1987, TRENDS IN IMMUNOLOGY has provided a critical platform for researchers, professionals, and students to access the latest advancements and integrative reviews in immunological research. The journal offers open access options, enhancing the accessibility of its high-impact content to a global audience. Researchers and practitioners rely on its pages not only for cutting-edge findings but also for comprehensive discussions that drive the future of immunology research.

JOURNAL OF EXPERIMENTAL MEDICINE

Pioneering Discoveries in Experimental Medicine
Publisher: ROCKEFELLER UNIV PRESSISSN: 0022-1007Frequency: 12 issues/year

JOURNAL OF EXPERIMENTAL MEDICINE, published by Rockefeller University Press, is a renowned peer-reviewed journal dedicated to advancing the field of experimental medicine since its inception in 1896. With an impressive impact factor and categorized in the Q1 quartile for Immunology, Immunology and Allergy, and Miscellaneous Medicine, this journal stands at the forefront of medical research and innovation. It provides a prestigious platform for scholars and practitioners to disseminate groundbreaking findings that drive the understanding of disease mechanisms and therapeutic strategies. While the journal is not open access, it maintains high visibility and engagement within the scientific community, fostering collaboration among researchers, professionals, and students alike. The journal's consistent ranking in the top percentiles of Scopus illustrates its significant impact and commitment to excellence in medical research.

HUMAN IMMUNOLOGY

Exploring Innovations in Immunity and Allergy
Publisher: ELSEVIER SCIENCE INCISSN: 0198-8859Frequency: 12 issues/year

HUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.

PARASITE IMMUNOLOGY

Exploring the Complexities of Immunological Defense.
Publisher: WILEYISSN: 0141-9838Frequency: 12 issues/year

PARASITE IMMUNOLOGY, published by Wiley, is a leading journal in the field of immunology and parasitology, with an ISSN of 0141-9838 and E-ISSN of 1365-3024. Since its inception in 1979, it has played a pivotal role in advancing our understanding of host-parasite interactions, immunological responses to parasitic infections, and the mechanisms of immunological resistance. The journal is adeptly positioned within the academic community, currently holding a prestigious Q2 ranking in Parasitology and a Q3 ranking in Immunology for 2023, indicating its significant influence and relevance. Its comprehensive scope attracts a diverse readership, contributing to the discourse surrounding novel therapeutic approaches and emerging challenges in parasitic diseases. With a consistent convergence of research until 2024, PARASITE IMMUNOLOGY is an essential resource for researchers, professionals, and students seeking to deepen their knowledge and foster collaboration in these dynamic fields. Although it is not an open-access journal, the insights shared within its pages are invaluable for shaping future research trajectories.

Immunological Medicine

Connecting Researchers to Transform Immunological Knowledge
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

Mucosal Immunology

Unveiling the Secrets of Mucosal Defense
Publisher: ELSEVIER SCIENCE INCISSN: 1933-0219Frequency: 6 issues/year

Mucosal Immunology, published by Elsevier Science Inc, is a leading journal dedicated to advancing the field of immunology with a particular focus on mucosal immunity. Since its inception in 2008, the journal has established itself as a premier source of cutting-edge research, evidenced by its impressive Q1 ranking in both Immunology and Allergy for 2023, and its notable positions within the top ranks of Scopus (Rank #21/233 in Immunology and Allergy and Rank #24/236 in Immunology and Microbiology). The journal serves as a vital resource for researchers, professionals, and students aiming to explore the complexities of mucosal immune responses and their implications in health and disease. While it operates under a subscription model, Mucosal Immunology is committed to disseminating quality research globally and enhancing collaborative efforts within the scientific community. Explore the latest findings and connect with influential scholarship in this rapidly evolving field.